Cargando…
Hydroxychloroquine/methylprednisolone/nafamostat: Delayed viral clearance and off label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119615/ http://dx.doi.org/10.1007/s40278-021-95849-3 |
Ejemplares similares
-
Methylprednisolone/prednisolone: Delayed viral clearance and off label use: 2 case reports
Publicado: (2020) -
Hydroxychloroquine/immunosuppressants: Delayed viral clearance, drug interaction and off label use: 3 case reports
Publicado: (2021) -
Nafamostat: Off-label use and hyperkalaemia: case report
Publicado: (2020) -
Hydroxychloroquine/mycophenolate-mofetil/tacrolimus: Delayed viral clearance, gastrointestinal adverse reactions and off-label use: case report
Publicado: (2021) -
Favipiravir/hydroxychloroquine/methylprednisolone: Nephrotoxicity following an off-label use: 2 case reports
Publicado: (2021)